Joan Gil Selected Research

acadesine

1/2017	The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells through the upregulation of NOXA and synergizes with ibrutinib, 5-aminoimidazole-4-carboxamide riboside or venetoclax.
10/2010	AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells.
5/2003	Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joan Gil Research Topics

Disease

18	Neoplasms (Cancer) 02/2022 - 01/2003
13	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017 - 04/2002
8	COVID-19 01/2022 - 11/2020
5	Acromegaly 02/2022 - 01/2020
4	Neuroblastoma 05/2012 - 08/2003
3	Infections 01/2022 - 11/2020
3	Leukemia 01/2021 - 03/2003
3	Breast Neoplasms (Breast Cancer) 01/2020 - 03/2014
2	Pituitary Neoplasms (Pituitary Adenoma) 02/2022 - 01/2021
2	Hematologic Neoplasms (Hematological Malignancy) 09/2021 - 03/2003
2	Pneumonia (Pneumonitis) 11/2020 - 11/2020
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2014 - 04/2013
2	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2010 - 05/2006
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2010 - 12/2006
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Frailty 10/2021
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 10/2021
1	Lung Neoplasms (Lung Cancer) 09/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Adenoma (Adenomas) 01/2021
1	Hypokalemia 11/2020
1	Multiple Myeloma 10/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2016
1	Pulmonary Arterial Hypertension 09/2013
1	Glioma (Gliomas) 04/2011
1	Glioblastoma (Glioblastoma Multiforme) 04/2011
1	Lung Diseases (Lung Disease) 04/2010

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2003
5	ProhibitinsIBA 09/2021 - 10/2016
4	LigandsIBA 01/2022 - 01/2020
4	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2022 - 01/2020
4	Pharmaceutical PreparationsIBA 01/2021 - 03/2003
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2020
3	acadesineIBA 01/2017 - 05/2003
3	nutlin 3IBA 04/2013 - 05/2006
2	Cadherins (E-Cadherin)IBA 01/2022 - 01/2020
2	tocilizumab (atlizumab)FDA Link 10/2021 - 11/2020
2	Messenger RNA (mRNA)IBA 01/2017 - 07/2011
2	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 04/2013
2	AICA ribonucleotide (ZMP)IBA 08/2013 - 10/2010
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2009 - 04/2002
2	Dopamine (Intropin)FDA LinkGeneric 07/2009 - 08/2003
2	ParaffinIBA 05/2009 - 11/2007
2	Formaldehyde (Formol)FDA Link 05/2009 - 11/2007
1	Growth Hormone (Somatotropin)IBA 02/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	AntibodiesIBA 10/2021
1	Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA 09/2021
1	rocaglamideIBA 09/2021
1	pasireotideIBA 01/2021
1	Troponin T (Troponin T1)IBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	PotassiumIBA 11/2020
1	Apoptosis Regulatory ProteinsIBA 01/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	glucose-regulated proteinsIBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Caspase 8 (Caspase-8)IBA 01/2018
1	prosteinIBA 01/2017
1	ibrutinibIBA 01/2017
1	venetoclaxIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 03/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2014
1	SurvivinIBA 01/2014
1	sepantroniumIBA 01/2014
1	Endothelin Receptor AntagonistsIBA 09/2013
1	ambrisentan FDA Link 09/2013
1	Bosentan (Tracleer)FDA Link 09/2013
1	ProstaglandinsIBA 09/2013
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 09/2013
1	GlucocorticoidsIBA 09/2012
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2012
1	kendine 92IBA 10/2011
1	Histone Deacetylase InhibitorsIBA 10/2011
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2011
1	RoscovitineIBA 07/2011
1	Small Interfering RNA (siRNA)IBA 04/2011
1	edelfosineIBA 04/2010
1	Carbon Nanotubes (Carbon Nanotube)IBA 04/2010
1	LipidsIBA 04/2010
1	SmokeIBA 04/2010
1	NF-kappa B (NF-kB)IBA 02/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2010
1	Chemokine CXCL12IBA 12/2009
1	Interleukin-4 (Interleukin 4)IBA 12/2009
1	A 443654IBA 12/2009

Therapy/Procedure

3	Therapeutics 02/2022 - 07/2011
3	Artificial Respiration (Mechanical Ventilation) 10/2021 - 11/2020
2	Precision Medicine 01/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 04/2013 - 12/2006
1	Length of Stay 10/2021
1	Ligation 10/2012
1	Radiotherapy 04/2011
1	Oral Administration 04/2010